Short Term Trading Week Starting: 26 Apr, page-69

MEB resubmiting its FDA 510(k) application for MEBsleep. After the last trial in 2020, the FDA said it required clinical data. MEB is moving ahead with this and will have a pre-submission meeting on July 1, 2021. MEB thinks it can complete the trial in about 6-8 weeks. Milestones are still a long way off but it might be one to watch in July when updates from the meeting and details regarding the trial should be released.

I should have pointed out that this is a dog stock but it can move nicely when it chooses to.